Activation of type IV procollagenases by human tumor-associated trypsin-2

Sorsa T, Salo T, Koivunen E, Tyynela J, Konttinen YT, Bergmann U, Tuuttila A, Niemi E, Teronen O, Heikkila P, Tschesche H, et al. (1997)

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Sorsa, T; Salo, T; Koivunen, E; Tyynela, J; Konttinen, YT; Bergmann, U; Tuuttila, A; Niemi, E; Teronen, O; Heikkila, P; Tschesche, HaraldUniBi; Leinonen, J
Abstract / Bemerkung
Increased production of proteinases, such as matrix metalloproteinases (MMPs), is a characteristic feature of malignant tumors. Some human cancers :Ind cell lines derived from them also express trypsinogen, but the function of the extrapancreatic trypsin has remained unclear, In this study we cloned and sequenced trypsinogen-a cDNA from human COLO 205 colon carcinoma cells and characterized the ability of the enzyme to activate latent human type TV procollagenases (proMMP-2 and proMMP-9). As shown by cloning and N-terminal amino acid sequencing, the amino acid sequence of tumor associated trypsin-a is identical to that of pancreatic trypsin-a. We found that both pancreatic trypsin-a and tumor cell-derived trypsin-a are efficient activators of proMMP-9 and are capable of activating proMMP-9 at a molar ratio of 1:1000, the lowest reported so far. Human trypsin-a was a more efficient activator than widely used bovine trypsin and converted the 92-kDa proMMP-9 to a single 77-kDa product that was not fragmented further. The single peptide bond cleaved by trypsin-a in proMMP-9 was Arg(87)-Phe(88), The generation of the 77-kDa species coincided with the increase in specific activity of MMP-9. In contrast, trypsin-2 only partially activated proMMP-2. Trypsin-a cleaved the Arg(99)-Lys(100) peptide bond of proMMP-2 generating 62-65-kDa MMP-2 species. Trypsin-a-induced proMMP-2 and -9 conversions were inhibited by tumor-associated trypsin inhibitor added either prior to or during activation indicating that proMMPs were not activated autocatalytically. Trypsin-2 also activated proMMPs associated with tissue inhibitor of matrix metalloproteinases, the complexes of which are thought to be the major MMP forms in vivo. The ability of human tumor cell-derived trypsin-a to activate latent MMPs suggests a role fbr trypsin-a in initiating the proteinase cascade that mediates tumor invasion and metastasis formation.
Page URI


Sorsa T, Salo T, Koivunen E, et al. Activation of type IV procollagenases by human tumor-associated trypsin-2. JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(34):21067-21074.
Sorsa, T., Salo, T., Koivunen, E., Tyynela, J., Konttinen, Y. T., Bergmann, U., Tuuttila, A., et al. (1997). Activation of type IV procollagenases by human tumor-associated trypsin-2. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(34), 21067-21074.
Sorsa, T, Salo, T, Koivunen, E, Tyynela, J, Konttinen, YT, Bergmann, U, Tuuttila, A, et al. 1997. “Activation of type IV procollagenases by human tumor-associated trypsin-2”. JOURNAL OF BIOLOGICAL CHEMISTRY 272 (34): 21067-21074.
Sorsa, T., Salo, T., Koivunen, E., Tyynela, J., Konttinen, Y. T., Bergmann, U., Tuuttila, A., Niemi, E., Teronen, O., Heikkila, P., et al. (1997). Activation of type IV procollagenases by human tumor-associated trypsin-2. JOURNAL OF BIOLOGICAL CHEMISTRY 272, 21067-21074.
Sorsa, T., et al., 1997. Activation of type IV procollagenases by human tumor-associated trypsin-2. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(34), p 21067-21074.
T. Sorsa, et al., “Activation of type IV procollagenases by human tumor-associated trypsin-2”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, 1997, pp. 21067-21074.
Sorsa, T., Salo, T., Koivunen, E., Tyynela, J., Konttinen, Y.T., Bergmann, U., Tuuttila, A., Niemi, E., Teronen, O., Heikkila, P., Tschesche, H., Leinonen, J., Osman, S., Stenman, U.H.: Activation of type IV procollagenases by human tumor-associated trypsin-2. JOURNAL OF BIOLOGICAL CHEMISTRY. 272, 21067-21074 (1997).
Sorsa, T, Salo, T, Koivunen, E, Tyynela, J, Konttinen, YT, Bergmann, U, Tuuttila, A, Niemi, E, Teronen, O, Heikkila, P, Tschesche, Harald, Leinonen, J, Osman, S, and Stenman, UH. “Activation of type IV procollagenases by human tumor-associated trypsin-2”. JOURNAL OF BIOLOGICAL CHEMISTRY 272.34 (1997): 21067-21074.

111 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation.
Nieminen MT, Listyarifah D, Hagström J, Haglund C, Grenier D, Nordström D, Uitto VJ, Hernandez M, Yucel-Lindberg T, Tervahartiala T, Ainola M, Sorsa T., Br J Cancer 118(3), 2018
PMID: 29149107
Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.
Lahdentausta L, Leskelä J, Winkelmann A, Tervahartiala T, Sorsa T, Pesonen E, Pussinen PJ., J Cardiovasc Transl Res 11(3), 2018
PMID: 29349668
The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen AM, Lazzara R, van der Schoor P, van der Schoor JG, Tervahartiala T, Gieselmann D, Sorsa T., Dis Markers 2018(), 2018
PMID: 30154936
Differential gene expression profiling of endometrium during the mid-luteal phase of the estrous cycle between a repeat breeder (RB) and non-RB cows.
Hayashi KG, Hosoe M, Kizaki K, Fujii S, Kanahara H, Takahashi T, Sakumoto R., Reprod Biol Endocrinol 15(1), 2017
PMID: 28335821
Biomarker development, from bench to bedside.
Stenman UH., Crit Rev Clin Lab Sci 53(2), 2016
PMID: 26287282
Do salivary and serum collagenases have a role in an association between obstructive sleep apnea syndrome and periodontal disease? A preliminary case-control study.
Nizam N, Basoglu OK, Tasbakan MS, Holthöfer A, Tervahartiala T, Sorsa T, Buduneli N., Arch Oral Biol 60(1), 2015
PMID: 25455127
Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak.
Shogan BD, Belogortseva N, Luong PM, Zaborin A, Lax S, Bethel C, Ward M, Muldoon JP, Singer M, An G, Umanskiy K, Konda V, Shakhsheer B, Luo J, Klabbers R, Hancock LE, Gilbert J, Zaborina O, Alverdy JC., Sci Transl Med 7(286), 2015
PMID: 25947163
Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.
Fang BA, Kovačević Ž, Park KC, Kalinowski DS, Jansson PJ, Lane DJ, Sahni S, Richardson DR., Biochim Biophys Acta 1845(1), 2014
PMID: 24269900
Common Matrix Metalloproteinases (MMP-8, -9, -25, and -26) Cannot Explain Dentigerous Cyst Expansion.
Suojanen J, Lehtonen N, Färkkilä E, Hietanen J, Teronen O, Sorsa T, Hagström J., J Clin Diagn Res 8(9), 2014
PMID: 25386530
SAR analysis and bioactive potentials of freshwater and terrestrial cyanobacterial compounds: a review.
Nagarajan M, Maruthanayagam V, Sundararaman M., J Appl Toxicol 33(5), 2013
PMID: 23172644
Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma.
Vilen ST, Salo T, Sorsa T, Nyberg P., ScientificWorldJournal 2013(), 2013
PMID: 23365550
Collagen degradation by tumor-associated trypsins.
Mirigian LS, Makareeva E, Koistinen H, Itkonen O, Sorsa T, Stenman UH, Salo T, Leikin S., Arch Biochem Biophys 535(2), 2013
PMID: 23541862
Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.
Piekkala M, Hagström J, Tanskanen M, Rintala R, Haglund C, Kolho KL., World J Gastroenterol 19(21), 2013
PMID: 23745029
Trypsin-mediated enzymatic degradation of type II collagen in the human vitreous.
van Deemter M, Kuijer R, Harm Pas H, Jacoba van der Worp R, Hooymans JM, Los LI., Mol Vis 19(), 2013
PMID: 23882137
Keratoconus and crosslinking: pharmacokinetic considerations.
Chan CC, Squissato V., Expert Opin Drug Metab Toxicol 9(12), 2013
PMID: 24001351
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML., Physiology (Bethesda) 28(6), 2013
PMID: 24186934
Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion.
Lauhio A, Rezes S, Tervahartiala T, Sziklai I, Pitkäranta A, Sorsa T., Ann Med 44(1), 2012
PMID: 21047154
Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer.
Mäkinen LK, Häyry V, Atula T, Haglund C, Keski-Säntti H, Leivo I, Mäkitie A, Passador-Santos F, Böckelman C, Salo T, Sorsa T, Hagström J., J Oral Pathol Med 41(5), 2012
PMID: 22084953
Neutrophil-derived matrix metalloproteinase-9 is a potent activator of trypsinogen in acinar cells in acute pancreatitis.
Awla D, Abdulla A, Syk I, Jeppsson B, Regnér S, Thorlacius H., J Leukoc Biol 91(5), 2012
PMID: 22100390
Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
Koskensalo S, Hagström J, Louhimo J, Stenman UH, Haglund C., Oncology 82(4), 2012
PMID: 22508321
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.
Vilen ST, Suojanen J, Salas F, Risteli J, Ylipalosaari M, Itkonen O, Koistinen H, Baumann M, Stenman UH, Sorsa T, Salo T, Nyberg P., Cancer Invest 30(8), 2012
PMID: 22909050
Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis.
Pan HY, Yamada H, Chida J, Wang S, Yano M, Yao M, Zhu J, Kido H., Cardiovasc Res 89(3), 2011
PMID: 21084314
Regulation of matrix metalloproteinase activity in health and disease.
Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO., FEBS J 278(1), 2011
PMID: 21087458
The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines.
Nakahata AM, Mayer B, Ries C, de Paula CA, Karow M, Neth P, Sampaio MU, Jochum M, Oliva ML., Biol Chem 392(4), 2011
PMID: 21781023
Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma.
Piirilä P, Lauhio A, Majuri ML, Meuronen A, Myllärniemi M, Tervahartiala T, Vuorinen K, Laitinen A, Alenius H, Kinnula VL, Sorsa T., Allergy 65(1), 2010
PMID: 19804449
Functional chimera of porcine pepsin prosegment and Plasmodium falciparum plasmepsin II.
Parr-Vasquez CL, Yada RY., Protein Eng Des Sel 23(1), 2010
PMID: 19910416
Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.
Jackson PL, Xu X, Wilson L, Weathington NM, Clancy JP, Blalock JE, Gaggar A., Mol Med 16(5-6), 2010
PMID: 20111696
Longitudinal study of salivary proteinases during pregnancy and postpartum.
Gürsoy M, Könönen E, Tervahartiala T, Gürsoy UK, Pajukanta R, Sorsa T., J Periodontal Res 45(4), 2010
PMID: 20412421
Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.
Koo BH, Han JH, Yeom YI, Kim DS., J Biol Chem 285(53), 2010
PMID: 21041295
Regulatory mechanism of matrix metalloprotease-2 enzymatic activity by factor Xa and thrombin.
Koo BH, Park MY, Jeon OH, Kim DS., J Biol Chem 284(35), 2009
PMID: 19581306
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Vilen ST, Nyberg P, Hukkanen M, Sutinen M, Ylipalosaari M, Bjartell A, Paju A, Haaparanta V, Stenman UH, Sorsa T, Salo T., Exp Cell Res 314(4), 2008
PMID: 18062964
Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.
Lauhio A, Sorsa T, Srinivas R, Stenman M, Tervahartiala T, Stenman UH, Grönhagen-Riska C, Honkanen E., Ann Med 40(4), 2008
PMID: 18428024
Proteolytic Activities of Oral Bacteria on ProMMP-9 and the Effect of Synthetic Proteinase Inhibitors.
Jie Bao G, Kari K, Tervahartiala T, Sorsa T, Meurman JH., Open Dent J 2(), 2008
PMID: 19088890
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD.
Ilumets H, Rytilä P, Demedts I, Brusselle GG, Sovijärvi A, Myllärniemi M, Sorsa T, Kinnula VL., Int J Chron Obstruct Pulmon Dis 2(3), 2007
PMID: 18229576
Metalloproteinase function in chronic rhinosinusitis with nasal polyposis.
Kostamo K, Tervahartiala T, Sorsa T, Richardson M, Toskala E., Laryngoscope 117(4), 2007
PMID: 17429873
Direct activation of gelatinase B (MMP-9) by hay dust suspension and different components of organic dust.
Simonen-Jokinen T, Maisi P, Tervahartiala T, McGorum B, Pirie S, Sorsa T., Vet Immunol Immunopathol 109(3-4), 2006
PMID: 16181685
Homocysteine causes cerebrovascular leakage in mice.
Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC., Am J Physiol Heart Circ Physiol 290(3), 2006
PMID: 16258031
Gingival tissue and crevicular fluid co-operation in adult periodontitis.
Beklen A, Tüter G, Sorsa T, Hanemaaijer R, Virtanen I, Tervahartiala T, Konttinen YT., J Dent Res 85(1), 2006
PMID: 16373682
Neurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo.
Obreja O, Rukwied R, Steinhoff M, Schmelz M., Exp Dermatol 15(1), 2006
PMID: 16364032
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.
Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P., Ann Med 38(5), 2006
PMID: 16938801
Immunohistopathology of Sjögren's syndrome.
Konttinen YT, Porola P, Konttinen L, Laine M, Poduval P., Autoimmun Rev 6(1), 2006
PMID: 17110311
Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides.
Heikkilä P, Suojanen J, Pirilä E, Väänänen A, Koivunen E, Sorsa T, Salo T., Int J Cancer 118(9), 2006
PMID: 16331606
Collagenolytic proteinases in keratoconus.
Mackiewicz Z, Määttä M, Stenman M, Konttinen L, Tervo T, Konttinen YT., Cornea 25(5), 2006
PMID: 16783151
Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
Määttä M, Tervahartiala T, Vesti E, Airaksinen J, Sorsa T., J Glaucoma 15(3), 2006
PMID: 16778646
Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
Tonouchi A, Ohtsuka M, Ito H, Kimura F, Shimizu H, Kato M, Nimura Y, Iwase K, Hiwasa T, Seki N, Takiguchi M, Miyazaki M., Am J Gastroenterol 101(7), 2006
PMID: 16863567
Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat.
Cederqvist K, Janer J, Tervahartiala T, Sorsa T, Haglund C, Salmenkivi K, Stenman UH, Andersson S., Pediatr Res 60(4), 2006
PMID: 16940237
Matrix metalloproteinase-7, -8, -9, -25, and -26 and CD43, -45, and -68 cell-markers in HIV-infected patients' saliva and gingival tissue.
Mellanen L, Lähdevirta J, Tervahartiala T, Meurman JH, Sorsa T., J Oral Pathol Med 35(9), 2006
PMID: 16968233
Assays of matrix metalloproteinases (MMPs) activities: a review.
Lombard C, Saulnier J, Wallach J., Biochimie 87(3-4), 2005
PMID: 15781313
Gelatinase-mediated migration and invasion of cancer cells.
Björklund M, Koivunen E., Biochim Biophys Acta 1755(1), 2005
PMID: 15907591
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
Bjartell A, Paju A, Zhang WM, Gadaleanu V, Hansson J, Landberg G, Stenman UH., Prostate 64(1), 2005
PMID: 15651064
Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.
Lintula S, Stenman J, Bjartell A, Nordling S, Stenman UH., Prostate 63(4), 2005
PMID: 15599939
Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkilä P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T., Exp Cell Res 307(2), 2005
PMID: 15950618
Pancreatic trypsin activates human promatrix metalloproteinase-2.
Lindstad RI, Sylte I, Mikalsen SO, Seglen PO, Berg E, Winberg JO., J Mol Biol 350(4), 2005
PMID: 15950241
Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue.
Stenman M, Ainola M, Valmu L, Bjartell A, Ma G, Stenman UH, Sorsa T, Luukkainen R, Konttinen YT., Am J Pathol 167(4), 2005
PMID: 16192646
Matrix metalloproteinases (MMPs) in oral diseases.
Sorsa T, Tjäderhane L, Salo T., Oral Dis 10(6), 2004
PMID: 15533204
Trypsin and host defence: a new role for an old enzyme.
Bajaj-Elliott M., Gut 52(2), 2003
PMID: 12524392
Differences in the activation mechanism between the alpha and beta subunits of human meprin.
Becker C, Kruse MN, Slotty KA, Köhler D, Harris JR, Rösmann S, Sterchi EE, Stöcker W., Biol Chem 384(5), 2003
PMID: 12817480
Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.
Steinberg J, Halter J, Schiller HJ, Dasilva M, Landas S, Gatto LA, Maisi P, Sorsa T, Rajamaki M, Lee HM, Nieman GF., J Surg Res 111(2), 2003
PMID: 12850461
Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer.
Kelloniemi E, Rintala E, Finne P, Stenman UH, Finnbladder Group., Urology 62(2), 2003
PMID: 12893328
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.
Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R., Biochem Biophys Res Commun 308(2), 2003
PMID: 12901881
Inhibition of matrix metalloproteinases by chemically modified tetracyclines in sepsis.
Maitra SR, Bhaduri S, Valane PD, Tervahartiala T, Sorsa T, Ramamurthy N., Shock 20(3), 2003
PMID: 12923502
Gelatinase B is associated with peri-implant bone loss.
Ma J, Kitti U, Hanemaaijer R, Teronen OP, Sorsa TA, Natah S, Tensing EK, Konttinen YT., Clin Oral Implants Res 14(6), 2003
PMID: 15015946
Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
Grenier D, Plamondon P, Sorsa T, Lee HM, McNamara T, Ramamurthy NS, Golub LM, Teronen O, Mayrand D., J Periodontol 73(1), 2002
PMID: 11846203
Regulation and interactions of MT1-MMP and MMP-20 in human odontoblasts and pulp tissue in vitro.
Palosaari H, Ding Y, Larmas M, Sorsa T, Bartlett JD, Salo T, Tjäderhane L., J Dent Res 81(5), 2002
PMID: 12097451
Specific monoclonal antibody against human trypsin.
Acosta Bas C, Baluja Conde IB, Brito Moreno AI, Rodriguez Lopez MR, Melchor A, Hernandez L, Frómeta A., Hybrid Hybridomics 21(4), 2002
PMID: 12193285
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Nyberg P, Moilanen M, Paju A, Sarin A, Stenman UH, Sorsa T, Salo T., J Dent Res 81(12), 2002
PMID: 12454097
Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A, Jacobsen J, Rasmuson T, Stenman UH, Ljungberg B., J Urol 165(3), 2001
PMID: 11176522
General aspects of anti-angiogenesis and cancer therapy.
Zogakis TG, Libutti SK., Expert Opin Biol Ther 1(2), 2001
PMID: 11727534
Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Yamamoto H, Iku S, Itoh F, Tang X, Hosokawa M, Imai K., Cancer 91(7), 2001
PMID: 11283933
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C, Leminen A, Wahlström T, Salo T, Stenman UH., Br J Cancer 84(10), 2001
PMID: 11355948
In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis.
Prikk K, Maisi P, Pirilä E, Sepper R, Salo T, Wahlgren J, Sorsa T., J Pathol 194(2), 2001
PMID: 11400153
Human trypsinogen in colorectal cancer.
Williams SJ, Gotley DC, Antalis TM., Int J Cancer 93(1), 2001
PMID: 11391623
Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.
Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M., Br J Cancer 85(5), 2001
PMID: 11531266
In vivo localization of gelatinases (MMP-2 and -9) by in situ zymography with a selective gelatinase inhibitor.
Pirilä E, Maisi P, Salo T, Koivunen E, Sorsa T., Biochem Biophys Res Commun 287(3), 2001
PMID: 11563862
Association of trypsin-2 with activation of gelatinase B and collagenase-2 in human bronchoalveolar lavage fluid in vivo.
Prikk K, Maisi P, Sepper R, Stenman UH, Salo T, Sorsa T., Ann Med 33(6), 2001
PMID: 11585105
Expression and regulation of MMP-20 in human tongue carcinoma cells.
Väänänen A, Srinivas R, Parikka M, Palosaari H, Bartlett JD, Iwata K, Grenman R, Stenman UH, Sorsa T, Salo T., J Dent Res 80(10), 2001
PMID: 11706946
Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: association with reduced cancer cell migration.
Lukkonen A, Sorsa T, Salo T, Tervahartiala T, Koivunen E, Golub L, Simon S, Stenman UH., Int J Cancer 86(4), 2000
PMID: 10797274
Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2.
Alm AK, Gagnemo-Persson R, Sorsa T, Sundelin J., Biochem Biophys Res Commun 275(1), 2000
PMID: 10944445
Expression and characterization of trypsinogen produced in the human male genital tract.
Paju A, Bjartell A, Zhang WM, Nordling S, Borgström A, Hansson J, Stenman UH., Am J Pathol 157(6), 2000
PMID: 11106574
Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.
Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP., J Biol Chem 274(19), 1999
PMID: 10224058
MMP inhibition and downregulation by bisphosphonates.
Teronen O, Heikkilä P, Konttinen YT, Laitinen M, Salo T, Hanemaaijer R, Teronen A, Maisi P, Sorsa T., Ann N Y Acad Sci 878(), 1999
PMID: 10415748
Tumor targeting with a selective gelatinase inhibitor.
Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkilä P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R., Nat Biotechnol 17(8), 1999
PMID: 10429241
Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M, Larjava H, Pirilä E, Maisi P, Salo T, Sorsa T, Uitto VJ., Exp Cell Res 251(1), 1999
PMID: 10438572
Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome.
Konttinen YT, Halinen S, Hanemaaijer R, Sorsa T, Hietanen J, Ceponis A, Xu JW, Manthorpe R, Whittington J, Larsson A, Salo T, Kjeldsen L, Stenman UH, Eisen AZ., Matrix Biol 17(5), 1998
PMID: 9822200
Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T., Adv Dent Res 12(2), 1998
PMID: 9972117
The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration.
Mäkelä M, Sorsa T, Uitto VJ, Salo T, Teronen O, Larjava H., Adv Dent Res 12(2), 1998
PMID: 9972137

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 9261109
PubMed | Europe PMC

Suchen in

Google Scholar